Divi's Laboratories Ltd.

NSE: DIVISLAB | BSE: 532488 | ISIN: INE361B01024 | Industry: Pharmaceuticals
| Expensive Performer
5914.5000 -217.00 (-3.54%)
NSE Aug 08, 2025 15:31 PM
Volume: 541.4K
 

5914.50
-3.54%
Axis Direct
We are positively surprised on fast remediation by Divi's followed by quick USFDA re-inspection. Form 483 observations issued in Dec 16 on Unit 2 facility (under Import Alert) have been confirmed as completed and resolved (EIR awaited) after USFDA re-inspection.
Divi's Laboratories Ltd. is trading below all available SMAs
More from Divi's Laboratories Ltd.
Recommended